| Literature DB >> 32082437 |
Jolanta Pulit-Prociak1, Jarosław Chwastowski1, Laura Bittencourt Rodrigues1, Marcin Banach1.
Abstract
In this study, an antimicrobial composition based on polyvinyl alcohol (PVA) and zinc oxide (ZnO) was developed. The aim of the work was to obtain a film-forming product for antimicrobial treatment of surfaces. To improve the physical, mechanical, and film-forming properties of the compositions, three natural stabilizing agents were added to the formulation: gelatine, guar gum and hydroxyethyl cellulose. Formulations with different concentrations of each stabilizer were tested, and the physicochemical properties of the obtained products were measured. The size of zinc oxide particles in obtained compositions varied from 232 to 692 nm. The compositions had a slight acidic nature. Their pH ranged from 6.84 to 6.99. The average density of products was equal to 1.37 × 103 (kg/m3). It was confirmed that zinc oxide nanoparticles do not penetrate through a model dermal membrane which is a desired effect concerning their toxicity. The antimicrobial activity of the obtained compositions was assessed against Aspergillus niger strain. After 24 h of studying, the growth inhibition was in 71% greater than in reference material. After statistical analysis of the results, it was concluded in order to achieve the most desirable physicochemical and utilitarian properties, the concentrations of gelatine, guar gum and hydroxyethylcellulose should be equal to 0.5%, 0.03% and 0.055%, respectively.Entities:
Keywords: 306 Thin film / Coatings; PVA; Zinc oxide nanoparticles; coatings
Year: 2019 PMID: 32082437 PMCID: PMC7006636 DOI: 10.1080/14686996.2019.1697617
Source DB: PubMed Journal: Sci Technol Adv Mater ISSN: 1468-6996 Impact factor: 8.090
Ingredients of the compositions.
| Component | Concentration in the product (%) |
|---|---|
| PVA | 7.00 |
| Sucrose | 0.12 |
| Hydroxyethyl cellulose | 0.010; 0.055 or 0.100 |
| Guar gum | 0.01; 0.03 or 0.05 |
| Gelatine | 0.1; 0.3 or 0.5 |
| Chitosan | 0.01 |
| Glycerol | 14.00 |
| ZnO nanoparticles | 3.00 |
| Casein | 0.40 |
| Water | up to 100 |
DOE for the stabilizing agent concentrations and measured properties.
| Sample | Input parameters | Output parameters | |||||
|---|---|---|---|---|---|---|---|
| Concentration in the product (%) | pH | Density × 103 (kg/m3) | Viscosity | ZnO nanoparticles size | |||
| Gelatine | Guar Gum | Hydroxyethyl cellulose | |||||
| L1 | 0.100 | 0.010 | 0.010 | 6.91 | 1.324 | 0.364 | 232 |
| L2 | 0.100 | 0.010 | 0.100 | 6.92 | 1.385 | 0.412 | 279 |
| L3 | 0.100 | 0.050 | 0.010 | 6.88 | 1.368 | 0.630 | 307 |
| L4 | 0.100 | 0.050 | 0.100 | 6.91 | 1.422 | 0.369 | 315 |
| L5 | 0.500 | 0.010 | 0.010 | 6.87 | 1.410 | 0.262 | 381 |
| L6 | 0.500 | 0.010 | 0.100 | 6.97 | 1.319 | 0.321 | 411 |
| L7 | 0.500 | 0.050 | 0.010 | 6.92 | 1.400 | 0.358 | 417 |
| L8 | 0.500 | 0.050 | 0.100 | 6.92 | 1.300 | 0.461 | 446 |
| L9 | 0.100 | 0.030 | 0.055 | 6.96 | 1.362 | 0.448 | 519 |
| L10 | 0.500 | 0.030 | 0.055 | 6.93 | 1.373 | 0.556 | 528 |
| L11 | 0.300 | 0.010 | 0.055 | 6.99 | 1.332 | 0.453 | 573 |
| L12 | 0.300 | 0.050 | 0.055 | 6.91 | 1.417 | 0.439 | 580 |
| L13 | 0.300 | 0.030 | 0.010 | 6.84 | 1.376 | 0.341 | 617 |
| L14 | 0.300 | 0.030 | 0.100 | 6.94 | 1.356 | 0.350 | 625 |
| L15 | 0.300 | 0.030 | 0.055 | 6.90 | 1.389 | 0.395 | 692 |
| Ref. | 0.300 | 0.030 | 0.055 | 5.43 | 1.368 | 0.290 | - |
A blank sample with no ZnO nanoparticles was also prepared as the reference material.
Figure 1.System for transdermal diffusion analysis.
Figure 2.(a) XRD of prepared ZnO nanoparticles; (b) FTIR spectra of prepared ZnO nanoparticles; (c) SEM microphotographs of prepared ZnO nanoparticles.
Figure 3.(a) Prepared composition before and after film formation; (b) XRD of prepared compositions; (c) FTIR spectra of prepared compositions.
Figure 4.(a) Mechanical properties of the films; (b) Dependence of absolute elongation on maximum bond strength; (c) Cellular growth inhibition after 8.64 × 104 s and 1.728 × 105 s.
Figure 5.Elemental mapping, SEM microphotographs and EDX collective spectra of samples (a) – composition L2; (b) composition L5; (c) composition L11.
Figure 6.Pareto charts for prepared compositions.
Figure 7.Approximation profiles for prepared compositions.